The global interventional spine devices market is predicted to grow at a steady compound annual growth rate of 10.5 percent until 2021, according to MILTECH.
Spinal Tech
Although reporting $19.7 billion total sales in the third quarter of 2017, Johnson & Johnson's spine division saw a decline in sales, according to Market Realist.
Highmark issued a new medical policy, "Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)."
The FDA cleared 19 spine-related medical devices in October.
ReWalk Robotics opened a public offering Nov. 17, according to CTECH.
Advertisement
Bain & Company released a new report, "A Path to Faster Growth for Healthcare Companies."
Here are six key notes on orthopedic and spine device companies from the past week.
To improve clinical outcomes and lower healthcare costs, Invibio Biomaterial Solutions made strategic investments in clinical study expertise, component manufacturing facilities and component testing.
Omar Ishrak, CEO of Medtronic, spoke about value-based care at OCTANe's Medical Technology Innovation Forum, according to Medical Design & Outsourcing.
Titan Spine reported the first successful surgeries using its Endoskeleton interbody fusion devices and surface technology in Australia.